378 related articles for article (PubMed ID: 29884175)
1. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
[TBL] [Abstract][Full Text] [Related]
4. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.
Rajaobelina K; Farges B; Nov S; Maury E; Cephise-Velayoudom FL; Gin H; Helmer C; Rigalleau V
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27235334
[TBL] [Abstract][Full Text] [Related]
5. Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.
de Vos LC; Mulder DJ; Smit AJ; Dullaart RP; Kleefstra N; Lijfering WM; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):933-8. PubMed ID: 24526694
[TBL] [Abstract][Full Text] [Related]
6. Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
Alkhami F; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Ferriere A; Ducos C; Mohammedi K; Fawaz S; Couffinhal T; Rigalleau V
Diabetes Metab; 2024 Mar; 50(2):101524. PubMed ID: 38346471
[TBL] [Abstract][Full Text] [Related]
7. Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation.
Kunimoto M; Yokoyama M; Shimada K; Matsubara T; Aikawa T; Ouchi S; Fukao K; Miyazaki T; Fujiwara K; Abulimiti A; Honzawa A; Shimada A; Yamamoto T; Amano A; Saitoh M; Morisawa T; Takahashi T; Daida H; Minamino T
Cardiovasc Diabetol; 2021 Oct; 20(1):208. PubMed ID: 34656131
[TBL] [Abstract][Full Text] [Related]
8. Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.
Schutte E; de Vos LC; Lutgers HL; Lambers Heerspink HJ; Wolffenbuttel BH; Vart P; Zeebregts CJ; Gansevoort RT; Lefrandt JD
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1709-14. PubMed ID: 27365407
[TBL] [Abstract][Full Text] [Related]
9. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
[TBL] [Abstract][Full Text] [Related]
10. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
[TBL] [Abstract][Full Text] [Related]
11. For diabetic type 1 patients, the skin autofluorescence predicts ulcers and amputations.
Rojubally S; Simoneau A; Monlun M; Foussard N; Blanco L; Domenge F; Mohammedi K; Ducasse E; Caradu C; Rigalleau V
J Diabetes Complications; 2021 Mar; 35(3):107808. PubMed ID: 33386214
[TBL] [Abstract][Full Text] [Related]
12. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
Rajaobelina K; Helmer C; Vélayoudom-Céphise FL; Nov S; Farges B; Pupier E; Blanco L; Hugo M; Gin H; Rigalleau V
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719154
[TBL] [Abstract][Full Text] [Related]
13. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
[TBL] [Abstract][Full Text] [Related]
14. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
[TBL] [Abstract][Full Text] [Related]
15. Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.
van Waateringe RP; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Lutgers HL; Wolffenbuttel BH
Eur J Clin Invest; 2016 May; 46(5):481-90. PubMed ID: 27002914
[TBL] [Abstract][Full Text] [Related]
16. Association of skin autofluorescence with plaque vulnerability evaluated by optical coherence tomography in patients with cardiovascular disease.
Fujino Y; Attizzani GF; Tahara S; Wang W; Takagi K; Naganuma T; Yabushita H; Tanaka K; Sato T; Watanabe Y; Mitomo S; Kurita N; Ishiguro H; Nakamura S; Hozawa K; Bezerra HG; Yamagishi SI; Nakamura S
Atherosclerosis; 2018 Jul; 274():47-53. PubMed ID: 29751284
[TBL] [Abstract][Full Text] [Related]
17. Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years.
Tiessen AH; Jager W; ter Bogt NC; Beltman FW; van der Meer K; Broer J; Smit AJ
Clin Chem Lab Med; 2014 Jan; 52(1):121-7. PubMed ID: 23612547
[TBL] [Abstract][Full Text] [Related]
18. Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events.
Sprenger HG; Bierman WF; Martes MI; Graaff R; van der Werf TS; Smit AJ
AIDS; 2017 Jan; 31(2):241-246. PubMed ID: 27763891
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
[TBL] [Abstract][Full Text] [Related]
20. Skin autofluorescence: Correlation with measures of diabetic sensorimotor neuropathy.
Stirban AO; Bondor CI; Florea B; Veresiu IA; Gavan NA
J Diabetes Complications; 2018 Sep; 32(9):851-856. PubMed ID: 30025785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
